Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.
about
Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causationCurrent Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral TherapyCounseling patients seropositive for human immunodeficiency virus. An approach for medical practice.AIDS and the lung. IntroductionEffects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndromeA new approach to estimating AIDS incubation times: results in homosexual infected men.Clinical course of anogenital warts in men infected with human immunodeficiency virusMonitoring of lymphocyte subpopulation changes in the assessment of HIV infection.HIV-1 P24 antigenaemia does not predict time of survival in AIDS patientsHerpes zoster and the stage and prognosis of HIV-1 infectionCytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infectionModified Kigali combined staging predicts risk of mortality in HIV-infected adults in Lusaka, Zambia.Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).Economic impact of HIV infection and coronary heart disease in immigrants to CanadaCourse of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study.Planning community-wide services for persons with HIV infection in an area of moderate incidence.Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitroPredictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.Five year prospective study of HIV infection in the Edinburgh haemophiliac cohort.Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine.Can repeated plasma donation by asymptomatic HIV-infected individuals delay the onset of AIDS?Clinical and immunological assessment of HIV infection.Transplantation in HIV+ patientsAttitudes of paediatricians to HIV and hepatitis B virus infectionIncidence of AIDS and excess of mortality associated with HIV in haemophiliacs in the United Kingdom: report on behalf of the directors of haemophilia centres in the United Kingdom.Clinical course of primary HIV infection: consequences for subsequent course of infection.Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group.Empirical treatment without bronchoscopy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndromeAIDS and the lung: update 1992. 2. Recent developments in the management of the pulmonary complications of HIV disease.Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection.The effect of CMV infection on progression of human immunodeficiency virus disease is a cohort of haemophilic men followed for up to 13 years from seroconversionDetection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.Measurement of human immunodeficiency virus type 1 p24 in serum by an ultrasensitive enzyme immunoassay, the two-site immune complex transfer enzyme immunoassay.Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. The Groupe d'Epidémiologie Clinique Du SIDA en Aquitaine.Antigen detection for human immunodeficiency virus.Markers predicting progression of human immunodeficiency virus-related disease.Infection and infectious diseases.Human immunodeficiency virus infection in Northern Ireland 1980-1989HIV Drug-Resistant Patient Information Management, Analysis, and Interpretation.Association of human immunodeficiency virus (HIV) p24 antigenemia with decrease in CD4+ lymphocytes and onset of acquired immunodeficiency syndrome during the early phase of HIV infection.
P2860
Q24627627-C6E709CF-558D-47F7-B084-CF1E88C6C9E4Q26750980-AEE50409-0AE0-4899-A71B-F9D556CA0495Q33558731-7BF8E74A-89FC-4A64-86D5-478A7BEA2540Q33604115-6B81225D-A35B-460E-B32C-537DA8818893Q33681857-EFF9228A-E660-4A71-8070-408564623C68Q33701449-D319571C-C22F-4C71-8048-00F9962F9F45Q33932150-F2009723-CB2D-41C8-B972-88B0E738C2A9Q33932583-D48BCD8D-C7AD-48ED-A5D8-15643F322E41Q33932589-CC81DE28-78E3-4566-BC24-7AB16C1CA070Q33937002-6D946426-DAA8-44C9-A58D-85899E89F1DAQ33997410-AB1607A6-9DA0-48B0-A1C6-A2AD223186A7Q34085355-28CDD979-95F4-4103-B50A-D4B76781B7F3Q34208618-885D2649-B688-4C3B-A023-5F94575BA163Q34275531-97EE3A20-F4B7-4C49-8AA7-E716CAC65EB6Q34276456-6B1F74FE-4538-48A5-B385-8E8BAFD18C7AQ34453139-3640E452-39A7-49B9-B834-394621439B73Q34570241-7AC6E8A7-A370-4910-8AF3-F0DAFE1405BDQ35035472-321E319C-45CC-4E1A-9D93-EDB3292D413BQ35171222-19211E0E-2B5F-4128-91D6-778D1FD68C71Q35178308-08D2ADD1-F018-4071-9B8D-2EC53177AF18Q35211596-D60BC8E2-E7E2-468E-84D4-7BCD917DD533Q35270154-93CD373C-F63B-4AA6-B2CD-2E07558EB53CQ35602443-183A9C7E-2889-4230-9901-B9D1CB1B31DBQ35627457-49338D0E-968F-4D25-A98A-C3FC263CFBBEQ35711654-5508E97D-5B66-485F-BEDE-B4F65A700A3CQ35714054-A64DDE4E-6BF3-4388-9603-742B02B1B172Q35820513-8F6C910D-CE95-4A82-AE22-AA0D68D43C06Q36203582-47997B70-9FB3-4067-A216-B95A875FA1C3Q36225746-E3710E12-2EF9-4D73-8A20-FF5663067508Q36361254-AA5927D6-63F0-4875-93FA-BD6C1CD7DAA2Q36503545-D858AF9C-C3F6-4078-9B47-0905886DEA3AQ36517066-1720D685-64CC-4CAA-B874-BE50381FA1AAQ36518155-D8DAD30C-5519-4F40-8DA1-794846F36BFDQ36568684-FA934348-D89A-42EE-A598-3EA57CAC1672Q36635240-278E7C76-A4E7-4EB8-AE7F-629438ADB8E1Q36640801-5343BEDB-8F31-4C86-BDE4-D19AA3F14ECBQ36723964-34FF3615-A733-4B63-8E33-874F12DBE3A1Q36750969-7F50B8E6-1FE7-4EB0-87B8-6A0EEA39A4AAQ36765273-103941B2-173F-4A19-92AE-562BB72B2845Q37172571-CE1A7A4D-C0F7-42C9-80B1-824988F34925
P2860
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Seropositivity for HIV and the ...... cisco General Hospital cohort.
@en
type
label
Seropositivity for HIV and the ...... cisco General Hospital cohort.
@en
prefLabel
Seropositivity for HIV and the ...... cisco General Hospital cohort.
@en
P2093
P2860
P1433
P1476
Seropositivity for HIV and the ...... cisco General Hospital cohort.
@en
P2093
J P Allain
P Bacchetti
R E Chaisson
P2860
P304
P407
P577
1988-03-01T00:00:00Z